CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey. Show more

389 Interpace Pkwy, Parsippany, NJ, 07054, United States

Biotechnology
Healthcare
Start AI Chat

Market Cap

509M

52 Wk Range

$5.60 - $17.43

Previous Close

$6.46

Open

$6.28

Volume

1,245,051

Day Range

$6.14 - $6.53

Enterprise Value

602.2M

Cash

55.72M

Avg Qtr Burn

N/A

Insider Ownership

8.00%

Institutional Own.

55.18%

Qtr Updated

09/30/25